Ran Cui
Impact in
- Biochemistry top 5%
- Antioxidant Activity and Oxidative Stress
- Obstetrics and Gynecology top 10%
- Uterine Myomas and Treatments
- Endometrial and Cervical Cancer Treatments
Papers in
-
- Lung Cancer Treatments and Mutations 7
- Oncology 14
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Qing Xu (8 shared papers)Juemin Fang (6 shared papers)Yulan Wang (4 shared papers)Yuanyuan Xiao (3 shared papers)Zhuqing Liu (6 shared papers)Mark N. Stein (1 shared paper)Yue Wen (1 shared paper)Edmund C. Lattime (1 shared paper)
- Journals
- Medicine (4 papers)PLoS ONE (4 papers)Oncotarget (3 papers)Journal of Ovarian Research (2 papers)Clinical and Experimental Rheumatology (1 paper)
- Partner nations
- ChinaTaiwanUnited States
In The Last Decade
Ran Cui
41 papers receiving 719 citations
Peers
Comparison fields: 5 of 111
- Biochemistry 107
- Obstetrics and Gynecology 73
- Reproductive Medicine 69
- Cancer Research 85
- Immunology 111
Countries citing papers authored by Ran Cui
This map shows the geographic impact of Ran Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Cui more than expected).
Fields of papers citing papers by Ran Cui
This network shows the impact of papers produced by Ran Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Cui. The network helps show where Ran Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Ran Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 136 | |
| 2 | 2016 | 76 | |
| 3 | 2017 | 55 | |
| 4 | 2021 | 47 | |
| 5 | 2019 | 45 | |
| 6 | 2012 | 37 | |
| 7 | 2015 | 29 | |
| 8 | 2018 | 25 | |
| 9 | 2016 | 25 | |
| 10 | 2017 | 24 | |
| 11 | 2017 | 23 | |
| 12 | 2014 | 17 | |
| 13 | 2022 | 16 | |
| 14 | 2022 | 15 | |
| 15 | 2019 | 15 | |
| 16 | Prognostic role of vascular endothelial growth factor in prostate cancer: a systematic review and meta-analysis. | 2015 | 14 |
| 17 | 2008 | 13 | |
| 18 | 2019 | 12 | |
| 19 | 2021 | 11 | |
| 20 | 2014 | 10 |
About Ran Cui
Ran Cui is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Rheumatology, Immunology and Molecular Biology, having authored 53 papers that have together received 728 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Spondyloarthritis Studies and Treatments (4 papers), Long-Term Effects of COVID-19 (3 papers), Autoimmune and Inflammatory Disorders Research (3 papers), Cancer Mechanisms and Therapy (3 papers) and Antioxidant Activity and Oxidative Stress (3 papers). The work is most often cited by research in Biochemistry (107 citations), Obstetrics and Gynecology (73 citations), Reproductive Medicine (69 citations), Cancer Research (85 citations) and Immunology (111 citations). Ran Cui has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Qing Xu, Juemin Fang, Yulan Wang, Yuanyuan Xiao, Zhuqing Liu, Mark N. Stein, Yue Wen, Edmund C. Lattime, Xiang‐Lin Tan and Chongdong Liu. Their work appears in journals such as Medicine, PLoS ONE, Oncotarget, Journal of Ovarian Research and Clinical and Experimental Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.